RIGL Operating Cash Flow Growth
Rigel Pharmaceuticals Inc · Operating Cash Flow Growth
RIGL Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported0.38%period ending
RIGL Quarterly Cash from Operations YoY % (-0.79% → 0.38%)
Year-over-year change
High-resolution chart · PNG
RIGL operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 0.3799% | |
| 405.1512% | |
| 51.5549% | |
| 10.8492% | |
| 10,011.5894% | |
| 82.1863% | |
| 332.4199% | |
| 1,695.2171% | |
| -94.9073% | |
| -23.0486% | |
| 71.5186% | |
| 89.7827% | |
| 145.9298% | |
| 84.1089% | |
| -14.7909% | |
| -29.1735% | |
| -123.3827% | |
| -28.4741% | |
| -22.5661% | |
| 47.1461% | |
| 493.3324% | |
| -545.1665% | |
| -61.3846% | |
| -33.0647% | |
| 15.6928% | |
| -443.5852% | |
| -182.8667% | |
| 27.0939% | |
| 38.3159% | |
| 97.5678% | |
| 159.0616% | |
| -14.0375% | |
| -38.6441% | |
| -12.677% | |
| -58.1755% | |
| 21.9795% | |
| -5.62% | |
| 7.3952% | |
| 9.6615% | |
| -138.6698% | |
| -1.5871% | |
| -224.6456% | |
| 8.3256% | |
| 48.4098% | |
| 9.0152% | |
| 209.4899% | |
| 20.3113% | |
| 11.628% | |
| 6.4584% | |
| 34.5785% | |
| 12.3782% | |
| -5.6968% | |
| -2.8014% | |
| -7.8976% | |
| -15.5463% | |
| -53.4042% | |
| -20.8273% | |
| -12.0888% | |
| -281.6712% | |
| 32.6968% | |
| -121.8454% | |
| 10.0857% | |
| 144.1179% | |
| 25.1241% | |
| 413.585% | |
| 20.5423% | |
| 14.2447% | |
| -3.498% | |
| -1.1587% | |
| -7.3191% | |
| -224.0597% | |
| -80.6452% | |
| -67.1728% | |
| -75.4227% | |
| 23.0734% | |
| -66.2341% | |
| -123.2821% | |
| -52.1636% | |
| -142.2024% | |
| 40.6783% | |
| 38.6238% | |
| -66.4752% | |
| 14.8029% | |
| -20.5586% | |
| 0.5793% | |
| 42.4008% | |
| 46.4311% | |
| -18.132% | |
| -25.5339% | |
| -148.3568% | |
| 32.5041% | |
| -124.9942% | |
| 18.9389% | |
| 13.9742% | |
| -390.3226% | |
| -59.6211% | |
| -97.9074% | |
| -0.7938% |